
Kara N. Maxwell, MD, PhD, discusses the risk of cancer for males carrying BRCA mutations.

Your AI-Trained Oncology Knowledge Connection!


Kara N. Maxwell, MD, PhD, discusses the risk of cancer for males carrying BRCA mutations.

Kara N. Maxwell, MD, PhD, discusses key takeaways from a real-world investigation of germline mutation rates in patients with metastatic prostate cancer.

Kara N. Maxwell, MD, PhD, discusses the accessibility of genetic testing in the community setting for patients with metastatic prostate cancer.

Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.

Kara Maxwell, MD, PhD discusses a study of genetic testing results in metastatic prostate cancer.

Published: August 9th 2024 | Updated: